Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Longoni

Showing results (681-690 of 824) with videos related to

Pageof 83
Sort By:
Clinical Genetics|April 8, 2014
Prevalence and penetrance of ZFPM2 mutations and deletions causing congenital diaphragmatic herniaM Longoni, M K Russell, F A High, et al.
Minerva Urology and Nephrology|March 22, 2023
Implications for diagnosis and treatment strategies in non-muscle invasive bladder cancer with variant histology: a systematic reviewGiuseppe Basile, Mario de Angelis, Riccardo Leni, et al.
European Urology Focus|September 25, 2025
Cancer-specific Mortality After Radical Nephrectomy and Thrombectomy for Renal Cell Carcinoma with Tumor Thrombus According to Histological SubtypesMichele Nicolazzini, Mattia Longoni, Fabian Falkenbach, et al.
European Journal of Neurology|May 29, 2025
Prognostic Value of Cerebral Hemodynamics Assessment on 24-h Transcranial Color-Coded Doppler Following a Successful ThrombectomySabrina Rossi, Matteo Paolucci, Giorgia Arnone, et al.
The Prostate|September 10, 2025
USPSTF Recommendation Against PSA Screening vs. Stage and Cancer-Specific Mortality in Localized Prostate CancerFabian Falkenbach, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 21, 2023
Identification of unknown impurities J, RRT 2.2, 2.4, 2.6 and 3.4 in tetralysal® capsulesStéphan Billié, Kevin Reversé, Jean-Marie Arlabosse, et al.
World Journal of Urology|June 6, 2026
Years of life lost from metastatic prostate cancer according to household incomeLeonardo Quarta, Calogero Catanzaro, Michele Nicolazzini, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 14, 2025
The Effect of Chronic Kidney Disease on Adverse In-Hospital Outcomes at Radical ProstatectomyFabian Falkenbach, Natali Rodriguez Peñaranda, Mattia Longoni, et al.
European Urology Oncology|July 17, 2025
Years of Life Lost in Metastatic and Locally Advanced Prostate CancerFabian Falkenbach, Quynh Chi Le, Mattia Longoni, et al.
Clinical Genitourinary Cancer|January 25, 2025
Clinically Meaningful Upstaging and Upgrading in Favorable Intermediate-Risk Radical Prostatectomy PatientsMattia Longoni, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
Pageof 83

Showing results (681-690 of 824) with videos related to

Sort By:
Pageof 83
Clinical Genetics|April 8, 2014
Prevalence and penetrance of ZFPM2 mutations and deletions causing congenital diaphragmatic herniaM Longoni, M K Russell, F A High, et al.
Minerva Urology and Nephrology|March 22, 2023
Implications for diagnosis and treatment strategies in non-muscle invasive bladder cancer with variant histology: a systematic reviewGiuseppe Basile, Mario de Angelis, Riccardo Leni, et al.
European Urology Focus|September 25, 2025
Cancer-specific Mortality After Radical Nephrectomy and Thrombectomy for Renal Cell Carcinoma with Tumor Thrombus According to Histological SubtypesMichele Nicolazzini, Mattia Longoni, Fabian Falkenbach, et al.
European Journal of Neurology|May 29, 2025
Prognostic Value of Cerebral Hemodynamics Assessment on 24-h Transcranial Color-Coded Doppler Following a Successful ThrombectomySabrina Rossi, Matteo Paolucci, Giorgia Arnone, et al.
The Prostate|September 10, 2025
USPSTF Recommendation Against PSA Screening vs. Stage and Cancer-Specific Mortality in Localized Prostate CancerFabian Falkenbach, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|July 21, 2023
Identification of unknown impurities J, RRT 2.2, 2.4, 2.6 and 3.4 in tetralysal® capsulesStéphan Billié, Kevin Reversé, Jean-Marie Arlabosse, et al.
World Journal of Urology|June 6, 2026
Years of life lost from metastatic prostate cancer according to household incomeLeonardo Quarta, Calogero Catanzaro, Michele Nicolazzini, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 14, 2025
The Effect of Chronic Kidney Disease on Adverse In-Hospital Outcomes at Radical ProstatectomyFabian Falkenbach, Natali Rodriguez Peñaranda, Mattia Longoni, et al.
European Urology Oncology|July 17, 2025
Years of Life Lost in Metastatic and Locally Advanced Prostate CancerFabian Falkenbach, Quynh Chi Le, Mattia Longoni, et al.
Clinical Genitourinary Cancer|January 25, 2025
Clinically Meaningful Upstaging and Upgrading in Favorable Intermediate-Risk Radical Prostatectomy PatientsMattia Longoni, Francesco Di Bello, Natali Rodriguez Peñaranda, et al.
Pageof 83